New England Capital Financial Advisors LLC
Position in VRCA — Verrica Pharmaceuticals Inc.
CIK 1964652
MERIDEN, CT
Position in VRCA
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,224
+$166 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 43 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRCA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026New England Capital Financial Advisors LLC holds $36,825 across 6 Biotechnology names. VRCA ranks #3 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRPT |
Sarepta Therapeutics, Inc.
|
1,100 | $19,767 | |
| 2 | BHVN |
Biohaven Ltd.
|
1,000 | $14,880 | |
| 3 | VRCA |
Verrica Pharmaceuticals Inc.
This page
|
200 | $1,224 | |
| 4 | HURA |
TuHURA Biosciences, Inc./NV
|
281 | $657 | |
| 5 | HRTX |
Heron Therapeutics, Inc. /De/
|
475 | $202 | |
| 6 | MREO |
Mereo BioPharma Group plc
|
300 | $95 |
All Filings in VRCA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,224 | 200 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,058 | 200 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,662 | 200 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $862 | 200 | Shares | Sole | 2025-10-22 | |
| 2025-03-31 | $884 | 2,000 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,400 | 2,000 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||